1. Home
  2. STOK vs ASAN Comparison

STOK vs ASAN Comparison

Compare STOK & ASAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$29.35

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Asana Inc.

ASAN

Asana Inc.

HOLD

Current Price

$6.88

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
ASAN
Founded
2014
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
STOK
ASAN
Price
$29.35
$6.88
Analyst Decision
Strong Buy
Hold
Analyst Count
10
14
Target Price
$39.20
$12.46
AVG Volume (30 Days)
900.7K
5.5M
Earning Date
05-08-2026
06-02-2026
Dividend Yield
N/A
N/A
EPS Growth
92.73
27.93
EPS
N/A
N/A
Revenue
$184,420,000.00
$790,806,000.00
Revenue This Year
N/A
$10.19
Revenue Next Year
$77.49
$7.91
P/E Ratio
N/A
N/A
Revenue Growth
404.50
9.25
52 Week Low
$12.25
$5.38
52 Week High
$40.22
$15.71

Technical Indicators

Market Signals
Indicator
STOK
ASAN
Relative Strength Index (RSI) 43.10 43.27
Support Level $28.22 $6.45
Resistance Level $33.51 $6.88
Average True Range (ATR) 1.64 0.52
MACD -0.20 -0.09
Stochastic Oscillator 28.37 22.32

Price Performance

Historical Comparison
STOK
ASAN

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About ASAN Asana Inc.

Asana Inc is the system of action for work, built for the Agentic Enterprise. It provides a comprehensive solution where humans and AI agents can collaborate effectively so that individuals work smarter, teams move faster, and organizations deliver results. Companies use Asana to connect their work to company goals and orchestrate mission-critical workflows like product launches, employee onboarding, resource planning, tracking company-wide strategic initiatives and more. It manages its operations and allocates resources as a single operating and reportable segment. The company generates revenues from subscriptions from paying customers accessing its cloud-based platform.

Share on Social Networks: